Seegene succeeds in developing reagents using AI for the first time
Seegene succeeded in developing a molecular diagnosis reagent only in 4 days with its self-developed automated AI reagent development system.
Seegene(CEO Jong-Yoon Chun), a molecular diagnosis company, announced on the 3rd the company succeeded in developing a meningoencephalitis reagent and a h...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.